Inventor · disambiguated record
Michel Lazdunski
Also filed as: LAZDUNSKI MICHEL · LAZDUNSKI MICHEL MAURICE JACQUES
20 granted patents·11 pending applications·84 citations·filing 1996–2024
93Inventor score
Files withCENTRE NAT RECH SCIENT13MOLEAC PTE LTD6LAZDUNSKI MICHEL2BOURINET EMMANUEL1BUSSEROLLES JÉRÔME1
Top patents by PatentIndex Score
31 records- 0182US2025073294A1Therapy for promoting cell growthMOLEAC PTE LTD·Filed 2024·Application pending·0 cites
- 0280US7132505B1Polypeptide inhibiting a proton-gated Na+ channel, a nucleic acid coding for such polypeptide and a method of manufacturing an ASIC1a channel blockerCENTRE NAT RECH SCIENT·Filed 2001·Granted Nov 7, 2006·14 cites·12 claims
- 0372US8063054B2Method of treatment of retinal ischemia with diazoxideLAZDUNSKI MICHEL·Filed 2005·Granted Nov 22, 2011·7 cites·7 claims
- 0472US7468422B2Mechanosensitive mammalian potassium channel activatable by polyunsaturated fatty acidsCENTRE NAT RECH SCIENT·Filed 2005·Granted Dec 23, 2008·1 cites·7 claims
- 0570US10188688B2Therapy for promoting cell growthMOLEAC PTE LTD·Filed 2016·Granted Jan 29, 2019·1 cites·6 claims
- 0670US6875599B2Mammalian secreted group III phospholipase A2CENTRE NAT RECH SCIENT·Filed 2001·Granted Apr 5, 2005·2 cites·1 claims
- 0769US2021346448A1Therapy for promoting cell growthMOLEAC PTE LTD·Filed 2021·Application pending·0 cites
- 0868US9289459B2Therapy for promoting cell growthLAZDUNSKI MICHEL MAURICE JACQUES·Filed 2010·Granted Mar 22, 2016·2 cites·6 claims
- 0968US8357659B2Method of treating pain or itching with APETx2 peptide toxinCENTRE NAT RECH SCIENT·Filed 2009·Granted Jan 22, 2013·2 cites·10 claims
- 1068US6962976B2Human TREK2, a stretch- and arachidonic acid-sensitive K+ channel activated by inhalational anesthetics and niluzoleCENTRE NAT RECH SCIENT·Filed 2001·Granted Nov 8, 2005·1 cites·4 claims
- 1168US6942979B1Method for screening substances capable of modulating the activity of a TRAAK potassium channelCENTRE NAT RECH SCIENT·Filed 2000·Granted Sep 13, 2005·5 cites·4 claims
- 1266US6812017B2Mammalian secreted group IIF phospholipase A2CT NAT DE LA RECH SCIENTIQUE C·Filed 2001·Granted Nov 2, 2004·3 cites·2 claims
- 1364US2025161395A1Spinal cord regeneration therapyMOLEAC PTE LTD·Filed 2023·Application pending·0 cites
- 1459US9511045B2Use of riluzole for treating or preventing the adverse effects of antineoplastic agentsBUSSEROLLES JÉRÔME·Filed 2011·Granted Dec 6, 2016·2 cites·19 claims
- 1559US6309855B1Family of mammalian potassium channels, their cloning and their use, especially for the screening of drugsCT NAT DE LA RECH CNRS·Filed 1998·Granted Oct 30, 2001·19 cites·13 claims
- 1659US2019167742A1Therapy for promoting cell growthMOLEAC PTE LTD·Filed 2019·Application pending·0 cites
- 1759US2009162368A1Mechanosensitive mammalian potassium channel activatable by polyunsaturated fatty acidsCENTRE NAT RECH SCIENT·Filed 2008·Application pending·0 cites
- 1850US2002032322A1Family of mammalian potassium channels, their cloning and their use, especially for the screening of drugsCENTRE NAT RECH SCIENT·Filed 2001·Application pending·0 cites
- 1949US7112403B1Method for the identification of anestheticsCNRS AND FABRICE DUPRAT·Filed 2000·Granted Sep 26, 2006·8 cites·9 claims
- 2046US7067625B1Isolated TWIK-1 potassium channel proteinsCENTRE NAT RECH SCIENT·Filed 2000·Granted Jun 27, 2006·0 cites·1 claims
- 2143US2002119139A1Cloning and recombinant expression of mammalian group XII secreted phospholipase A2Filed 2001·Application pending·0 cites
- 2242US2002094558A1Family of mammalian potassium channels, their cloning and their use, especially for the screening of drugsCENTRE NAT RECH SCIENT·Filed 2001·Application pending·0 cites
- 2340US2012183580A1Analgesic Composition for Transbuccal AdministrationLAZDUNSKI MICHEL·Filed 2011·Application pending·0 cites
- 2438US6239156B1Method for the prevention of ischemic spinal cord injury caused by aortic crossclampingCENTRE NAT RECH SCIENT·Filed 2000·Granted May 29, 2001·0 cites·25 claims
- 2538US6013470AFamily of mammalian potassium channels, their cloning and their use especially for the screening of drugsCENTRE NAT RECH SCIENT·Filed 1996·Granted Jan 11, 2000·6 cites·15 claims
- 2637US6287859B1Identification, functional expression and chromosal localization of a sustained human proton-gated cation channelCENTRE NAT RECHERCHE·Filed 1999·Granted Sep 11, 2001·11 cites·2 claims
- 2737US2003049697A1Family of mechanosensitive human potassium channels activated by polyunsaturated fatty acids and their useCENTRE NAT RECH SCIENT·Filed 2002·Application pending·0 cites
- 2834US2013287870A1Novel uses for traditional chinese medicineMOLEAC PTE LTD·Filed 2013·Application pending·0 cites
- 2931US9448242B2Use of K2P potassium channel activators as antalgicsESCHALIER ALAIN·Filed 2010·Granted Sep 20, 2016·0 cites·4 claims
- 3026US8664179B2Identification of novel antagonist toxins of T-type calcium channel for analgesic purposesBOURINET EMMANUEL·Filed 2010·Granted Mar 4, 2014·0 cites·12 claims
- 3123US8987207B2Peptides which have analgesic effects and which inhibit ASIC channelsLINGUEGLIA ÉRIC·Filed 2011·Granted Mar 24, 2015·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Michel Lazdunski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →